__NUXT_JSONP__("/drugs/Sibrotuzumab", (function(a,b,c){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"216669-97-5",chebiId:b,chemicalFormula:b,definition:"A humanized monoclonal antibody (MoAb) against human fibroblast activation protein (FAP). FAP is a 95 kDa cell surface glycoprotein and an inducible tumor stromal antigen of epithelial cancers and of a subset of soft tissue sarcomas. FAP shows a very limited distribution pattern in normal tissues, thereby sibrotuzumab has possible diagnostic and therapeutic applications in epithelial cancers.",fdaUniiCode:"552U6E1NIW",identifier:"C156438",preferredName:a,semanticType:"Amino Acid, Peptide, or Protein",subclassOf:["C129822","C20401"],synonyms:["HuMoAb F19","Humanized F19 Monoclonal Antibody","SIBROTUZUMAB",a]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FSibrotuzumab",extension:".json",createdAt:c,updatedAt:c}}],fetch:{},mutations:void 0}}("Sibrotuzumab","","2021-10-30T13:34:22.963Z")));